07.10.2012
- Novartis is keen to maintain its dividend and is looking to boost growth via mid-sized acquisitions, though big deals are unlikely, the Swiss drugmaker's chief executive said in a...
12.03.2012
- Bayer is sounding out its debt financing options with banks to prepare for takeover opportunities such as one that may arise from Pfizer's mooted exit from veterinary medicine...
31.01.2011
- A bolt-on acquisition in animal health would "make a lot of sense" for diversified Swiss drugmaker Novartis, its chief executive said on Friday. Novartis, which last month wrapped...
